The comparison of QFT-Plus and T-Spot.TB for the diagnosis of tuberculosis infection in rheumatoid arthritis patients.

The comparison of QFT-Plus and T-Spot.TB for the diagnosis of tuberculosis infection in rheumatoid arthritis patients. - The comparison of QFT-Plus and T-Spot.TB for the diagnosis of tuberculosis infection in rheumatoid arthritis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021165

Enrollment

200

Registered

2016-03-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis patients.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rheumatoid patients. All participants are given sufficient information about this study, and then written informed consents are obtained from them.

Exclusion criteria

Exclusion criteria: The patients who are judged to be inapropriate for this study.

Design outcomes

Primary

Measure	Time frame
To calculate the positive rates of QFT-Plus and T-Spot.TB in rheumatoid arthritis patients.	—

Secondary

Measure	Time frame
To calculate the negative and indeterminant rates of QFT-Plus and T-Spot.TB in rheumatoid arthritis patients. The negative predictive value is analyzed during observation period.	—

Countries

Japan

Contacts

Public ContactSatoru Ishikawa

National Hospital Organization Chiba-East-Hospital Department of Respiratory Medicine

tetsu.is@gmail.com+81-43-261-5171

Outcome results